新闻和见解

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds
OrbiMed Logo

奥博资本

OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

Read More
PortCo

被投公司

Cullinan Therapeutics Licenses Rights to Velinotamig, a Clinical-Stage...

Read More
Sionna Logo

被投公司

Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719...

Read More
Corvus Pharmaceuticals Logo

被投公司

Corvus Pharmaceuticals Announces Full Data from Cohort 3 of Placebo-Controlled...

Read More
Avenzo Therapeutics Logo

被投公司

Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-1418, a Potential...

Read More
Verastem Oncology Logo

被投公司

Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’...

Read More
PortCo

被投公司

OnCusp Therapeutics Announces Encouraging Initial Phase 1a Results from Ongoing...

Read More
port-co

被投公司

Curevo Enrolls First Participants in Phase 2 Extension Trial

Read More
PortCo

被投公司

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting...

Read More
port-co

被投公司

Lilly to expand its pain pipeline with acquisition of SiteOne Therapeutics

Read More
Verastem Oncology Logo

被投公司

Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating...

Read More

被投公司

Sirius Therapeutics and CRISPR Therapeutics Announce Multi-Target Collaboration...

Read More
Triveni Bio Logo

被投公司

Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509,...

Read More